Oral semaglutide, including FDA-approved oral Wegovy formulations, has expanded access for individuals seeking non-injectable alternatives while maintaining therapeutic efficacy under physician guidance
Mechanism of Action: We utilize medications that align with our holistic approach
This once-weekly injection works as an appetite suppressant, supporting healthier portion control and promoting weight management when combined with a balanced diet and exercise
This expanded semaglutides clinical reach significantly
It is important to note that compounded versions of drugs like Wegovy are not approved by the FDA
Infections typically raise blood sugar, but the combination of illness, antibiotics, reduced food intake due to nausea, and semaglutide's glucose-lowering effects can create unpredictable patterns